The vendor onboarding workflow begins with a Microsoft Form, where users submit their requests. These submissions are then routed through a structured approval process involving key stakeholders, such ...

The U.S. Food and Drug Administration is delaying by three months its decision on whether or not to approve tolebrutinib for ...

The FDA today approved Biogen and Alkermes’ diroximel fumarate, an oral agent, to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, ...

Genentech, a member of the Roche Group, has won FDA approval for the first treatment indicated for both relapsing and primary progressive forms of multiple sclerosis (MS). Ocrevus™ (ocrelizumab) is a ...